Instem PLC | Cash Flow

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
698.00
212.00
361.00
23.00
797.00
1,677
Depreciation, Depletion & Amortization
716.00
1,064.00
1,172.00
1,203.00
1,590.00
1,670
Other Funds
44.00
104.00
1,584.00
1,192.00
466.00
309
Funds from Operations
1,370.00
1,380.00
2,395.00
34.00
1,921.00
3,656
Changes in Working Capital
644.00
889.00
109.00
85.00
535.00
1,458
Net Operating Cash Flow
2,014.00
491.00
2,504.00
119.00
1,386.00
2,198
Capital Expenditures
578.00
493.00
725.00
1,003.00
1,634.00
Sale of Fixed Assets & Businesses
1,134.00
-
-
-
-
Net Investing Cash Flow
2,154.00
795.00
1,683.00
3,383.00
2,351.00
Issuance/Reduction of Debt, Net
250.00
-
303.00
-
-
Net Financing Cash Flow
250.00
-
291.00
4,823.00
29.00
Net Change in Cash
397.00
377.00
507.00
2,006.00
1,125.00
Free Cash Flow
1,843.00
367.00
2,391.00
6.00
1,269.00
Net Assets from Acquisitions
2,710.00
-
-
2,347.00
687.00
Change in Capital Stock
-
-
12.00
4,823.00
29.00
Exchange Rate Effect
7.00
73.00
23.00
447.00
189.00
Other Uses
-
302.00
958.00
33.00
30.00

About Instem

View Profile
Address
Diamond Way
Stone Staffordshire ST15 0SD
United Kingdom
Employees -
Website http://instem.com
Updated 07/08/2019
Instem Plc engages in the provision of information technology solutions and services to the global health and life sciences community. Its products include animal care information system, alphadas, ames study manager, comet assay iv, cyto study manager, logbook eln, notocord-hem, provantis preclinical, samarind rms, sorcerer colony counter, send explorer, submit send, srs ioinformatics, and trp resource planning and services include data management, regulatory information management, solution deployment an validation. The company was founded in 1969 and is headquartered in Stone, the United Kingdom.